US63008J1088 - Common Stock - After market: 0.3 0 (-1.61%)
NASDAQ:NAOV (1/30/2023, 7:10:58 PM)-0.01 (-2.87%)
|GICS Sector||Health Care|
|GICS Industry||Health Care Equipment & Supplies|
|Earnings (Last)||11-14 2022-11-14/bmo||Earnings (Next)||N/A N/A|
|Ins Owners||0.4%||Inst Owners||4.5%|
Find more stocks on Nasdaq
Find more stocks on the USA
Find competitors from the same sector on the USA
Find competitors from the same industry on the USA
Find stocks with similar TA and Setup ratings on the USA
Find stocks with similar Fundamental rating on the USA
Find the competitors with the best technical ratings on the USA
Find the competitors with the best technical and setup ratings on the USA
Find the competitors with the best fundamentals on the USA
Find the competitors with the best valuation on the USA
Find the competitors with the best dividend on the USA
Find the competitors with the best analyst ratings on the USA
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The company is headquartered in Elmsford, New York and currently employs 12 full-time employees. The company went IPO on 2015-04-24. The firm is focused on developing noninvasive biological response-activating devices utilizing its low intensity surface acoustic wave (SAW) technology, which targets biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products, which are in various stages of clinical and market development consist of UroShield, PainShield and WoundShield. Its UroShield is an ultrasound-based product that prevents bacterial colonization and biofilm in urinary catheters. Its PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures. Its PainShield family of products include PainShield MD, PainShield Plus and PainShield Relief. WoundShield is a patch-based therapeutic ultrasound device developed to facilitate tissue regeneration and wound healing. Its wholly owned subsidiary is NanoVibronix Ltd.
525 Executive Blvd
Elmsford NEW YORK 10523
CEO: Brian Murphy
Chinese stocks are on the rise Tuesday as shares from companies in the country rebound from a dip yesterday caused by Covid restrictions.
NanoVibronix (NAOV) stock is falling on Tuesday following news of a direct offering from the therapeutic ultrasound technology company.
Here you can normally see the latest stock twits on NAOV, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.